Apple Podcasts , Spotify, Listen Here
In this episode, we cover the latest trial on tocilizumab, the preliminary analysis of the RECOVERY trial. While early trials were disappointing, REMAP-CAP and the RECOVERY trial have signaled mortality benefits when combined with steroids. Other tocilizumab trials include EMPACTA, TOCIBRAS, COR-IMUNO-TOCI, BACC Bay, RCT-TCZ-COVID

